Patents by Inventor Roger Hart

Roger Hart has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 8940878
    Abstract: Methods of purifying proteins expressed in non-mammalian expression systems in a non-native soluble form directly from cell lysate are disclosed. Methods of purifying proteins expressed in non-mammalian expression systems in a non-native limited solubility form directly from a refold solution are also disclosed. Resin regeneration methods are also provided.
    Type: Grant
    Filed: June 24, 2010
    Date of Patent: January 27, 2015
    Assignee: Amgen Inc.
    Inventors: Joseph Edward Shultz, Roger Hart
  • Publication number: 20140329227
    Abstract: Methods of inactivation of a virus in a sample comprising a protein component are provided. Also provided are methods of reducing protein degradation or modification in to the presence of a reactive species, such as a reactive species generated as a result of UV exposure, are also provided. In another aspect, a method of reducing oxidation of methionine residues, tryptophan residues or both methionine and tryptophan residues in a protein subjected to UV light is provided. The disclosed methods can be performed at any scale and can be automated as desired.
    Type: Application
    Filed: October 25, 2012
    Publication date: November 6, 2014
    Inventors: Joseph Edward Ssultz, Roger Hart, Brent Welborn
  • Publication number: 20120214204
    Abstract: The invention relates to cell culture media optimized for exposure to ultraviolet C (UVC) light exposure and related methods.
    Type: Application
    Filed: February 17, 2012
    Publication date: August 23, 2012
    Applicant: AMGEN INC.
    Inventors: Roger HART, Robert Michael Boychyn
  • Publication number: 20100331526
    Abstract: Methods of purifying proteins expressed in non-mammalian expression systems in a non-native soluble form directly from cell lysate are disclosed. Methods of purifying proteins expressed in non-mammalian expression systems in a non-native limited solubility form directly from a refold solution are also disclosed. Resin regeneration methods are also provided.
    Type: Application
    Filed: June 24, 2010
    Publication date: December 30, 2010
    Applicant: AMGEN INC.
    Inventors: Joseph Edward Shultz, Roger Hart
  • Publication number: 20100324269
    Abstract: A method of refolding proteins expressed in non-mammalian cells present in concentrations of 2.0 g/L or higher is disclosed. The method comprises identifying the thiol pair ratio and the redox buffer strength to achieve conditions under which efficient folding at concentrations of 2.0 g/L or higher is achieved and can be employed over a range of volumes, including commercial scale.
    Type: Application
    Filed: June 21, 2010
    Publication date: December 23, 2010
    Applicant: AMGEN INC.
    Inventors: Joseph Edward Shultz, Roger Hart, Ronald Nixon Keener, III
  • Patent number: 6673251
    Abstract: A method of handling grey water and optionally at least a portion of the black water for disposal from vehicles such as boats, recreational vehicles or rural dwellings such as cottages, camps and the like, not having direct access to sewer systems, involves the treatment of such waste water with ozone. A batch system is used whereby a predetermined quantity of water to be treated is captured in a treatment tank. A circulating pump withdraws water from the tank and pushes the water along a treatment conduit, the conduit containing an ozone/water mixer and returns the water to the treatment tank. The treatment conduit has a discharge valve that is maintained in a closed position for a selected period of time. Ozone is fed to the ozone/water mixer from an ozone generator which is advantageously fitted with an air pump to pressurize the feed gas.
    Type: Grant
    Filed: April 26, 2002
    Date of Patent: January 6, 2004
    Assignee: Great Lakes Clean Water Limited Partnership
    Inventors: Graham Edward Swales, James Edward Swales, Thomas W. Bain, Hubert Roger Hart
  • Publication number: 20020175128
    Abstract: A method of handling grey water and optionally at least a portion of the black water for disposal from vehicles such as boats, recreational vehicles or rural dwellings such as cottages, camps and the like, not having direct access to sewer systems, involves the treatment of such waste water with ozone. A batch system is used whereby a predetermined quantity of water to be treated is captured in a treatment tank. A circulating pump withdraws water from the tank and pushes the water along a treatment conduit, the conduit containing an ozone/water mixer and returns the water to the treatment tank. The treatment conduit has a discharge valve that is maintained in a closed position for a selected period of time. Ozone is fed to the ozone/water mixer from an ozone generator which is advantageously fitted with an air pump to pressurize the feed gas. After the selected treatment time, the batch is discharged to waste through the discharge valve.
    Type: Application
    Filed: April 26, 2002
    Publication date: November 28, 2002
    Applicant: Great Lakes Clean Water Limited Partnership
    Inventors: Graham Edward Swales, James Edward Swales, Thomas W. Bain, Hubert Roger Hart
  • Patent number: 6402945
    Abstract: A method of handling grey water and optionally at least a portion of black water for disposal from vehicles such as boats, recreational vehicles or rural dwellings such as cottages, camps and the like, not having direct access to sewer systems, involves the treatment of such waste water with ozone. A batch system is used whereby a predetermined quantity of water to be treated is captured in a treatment tank. A circulating pump withdraws water from the tank and pushes the water along a treatment conduit, the conduit containing an ozone/water mixer and returns the water to the treatment tank. The treatment conduit has a discharge valve that is maintained in a closed position for a selected period of time. Ozone is fed to the ozone/water mixer from an ozone generator which is advantageously fitted with an air pump to pressurize the feed gas. After the selected treatment time, the batch is discharged to a drain through the discharge valve.
    Type: Grant
    Filed: March 22, 2000
    Date of Patent: June 11, 2002
    Assignee: Great Lakes Clean Water Limited
    Inventors: Graham Edward Swales, James Edward Swales, Thomas W. Bain, Hubert Roger Hart
  • Patent number: 5927330
    Abstract: A high volume rotary selector valve having a modular structure is disclosed. The disclosed device operates to select one of a plurality of individual source lines of pressurized oil, gas, or other matter to divert the contents of the selected line to a predetermined destination for metering, testing, or sampling without interrupting the flow from other source lines. The modular design permits a large number of input lines to be attached to the valve without a corresponding increase in the valve's diameter or material thickness. Additionally, the modular design affords the user the ability to upgrade an existing selector valve system to increase the number of inlet ports, change the size of the inlet or outlet ports, or change the inlet or outlet port connector types.
    Type: Grant
    Filed: February 6, 1996
    Date of Patent: July 27, 1999
    Assignee: Oil States Industries
    Inventors: Randy Minton, Roger Hart, Richard Castillo
  • Patent number: 5808006
    Abstract: A composition is provided comprising about 0.1 to 15 mg/ml of a polypeptide in a buffer having a pH of about 7-12 comprising about 5-40% (v/v) of an alcoholic or polar aprotic solvent, about 0.2 to 3M of an alkaline earth, alkali metal, or ammonium salt, about 0.1 to 9M of a chaotropic agent, and about 0.01 to 15 .mu.M of a copper or manganese salt. The buffer is suitably used in a method for refolding improperly folded polypeptides.
    Type: Grant
    Filed: October 11, 1994
    Date of Patent: September 15, 1998
    Assignee: Genentech, Inc.
    Inventors: Stuart Builder, Roger Hart, Philip Lester, David Reifsnyder
  • Patent number: 5756672
    Abstract: A composition is provided comprising about 0.1 to 15 mg/mL of a polypeptide in a buffer having a pH of about 7-12 comprising about 5-40% (v/v) of an alcoholic or polar aprotic solvent, about 0.2 to 3M of an alkaline earth, alkali metal, or ammonium salt, about 0.1 to 9M of a chaotropic agent, and about 0.01 to 15 .mu.M of a copper or manganese salt. The buffer is suitably used in a method for refolding improperly folded polypeptides.
    Type: Grant
    Filed: June 6, 1995
    Date of Patent: May 26, 1998
    Assignee: Genentech, Inc.
    Inventors: Stuart Builder, Roger Hart, Philip Lester, David Reifsnyder
  • Patent number: 5723310
    Abstract: A method is described for isolating an exogenous polypeptide in a non-native conformation from cells, such as an aqueous fermentation broth, in which it is prepared comprising contacting the polypeptide with a chaotropic agent and preferably a reducing agent and with phase-forming species to form multiple aqueous phases, with one of the phases being enriched in the polypeptide and depleted in the biomass solids and nucleic acids originating from the cells. Preferably, the method results in two aqueous phases, with the upper phase being enriched in the polypeptide.
    Type: Grant
    Filed: February 7, 1995
    Date of Patent: March 3, 1998
    Assignee: Genentech, Inc.
    Inventors: Stuart Builder, Roger Hart, Philip Lester, John Ogez, David Reifsnyder
  • Patent number: 5695958
    Abstract: A method is described for isolating an exogenous polypeptide in a non-native conformation from cells, such as an aqueous fermentation broth, in which it is prepared comprising contacting the polypeptide with a chaotropic agent and preferably a reducing agent and with phase-forming species to form multiple aqueous phases, with one of the phases being enriched in the polypeptide and depleted in the biomass solids and nucleic acids originating from the cells. Preferably, the method results in two aqueous phases, with the upper phase being enriched in the polypeptide.
    Type: Grant
    Filed: May 17, 1995
    Date of Patent: December 9, 1997
    Assignee: Genentech, Inc.
    Inventors: Stuart Builder, Roger Hart, Philip Lester, John Ogez, David Reifsnyder
  • Patent number: 5663304
    Abstract: A composition is provided comprising about 0.1 to 15 mg/mL of a polypeptide in a buffer having a pH of about 7-12 comprising about 5-40% (v/v) of an alcoholic or polar aprotic solvent, about 0.2 to 3M of an alkaline earth, alkali metal, or ammonium salt, about 0.1 to 9M of a chaotropic agent, and about 0.01 to 15 .mu.M of a copper or manganese salt. The buffer is suitably used in a method for refolding improperly folded polypeptides.
    Type: Grant
    Filed: August 20, 1993
    Date of Patent: September 2, 1997
    Assignee: Genentech, Inc.
    Inventors: Stuart Builder, Roger Hart, Philip Lester, David Reifsnyder
  • Patent number: 5650705
    Abstract: A motor control system (10) for controlling a multiple number of motors, each motor having a multiple number of phases. System (10) can be used to dynamically vary the step sizes from microsteps to full steps (i.e. "syncro-stepping the motor").
    Type: Grant
    Filed: February 13, 1995
    Date of Patent: July 22, 1997
    Inventor: John Roger Hart
  • Patent number: 5407810
    Abstract: A method is described for isolating an exogenous polypeptide in a non-native conformation from cells, such as an aqueous fermentation broth, in which it is prepared comprising contacting the polypeptide with a chaotropic agent and preferably a reducing agent and with phase-forming species to form multiple aqueous phases, with one of the phases being enriched in the polypeptide and depleted in the biomass solids and nucleic acids originating from the cells. Preferably, the method results in two aqueous phases, with the upper phase being enriched in the polypeptide.
    Type: Grant
    Filed: August 20, 1993
    Date of Patent: April 18, 1995
    Assignee: Genentech, Inc.
    Inventors: Stuart Builder, Roger Hart, Philip Lester, John Ogez, David Reifsnyder